Mercado global de tratamento da gravidez extrauterina – Tendências do setor e previsão para 2029

Análise de mercado e insights do mercado de tratamento da gravidez extrauterina

A Data Bridge Market Research analisa que o tratamento da gravidez extrauterina apresentará um CAGR de cerca de 5,40% para o período previsto de 2022-2029. A crescente procura por modalidades direcionadas de terapias, o aumento das atividades de investigação e desenvolvimento para o desenvolvimento de novos medicamentos e terapias e o aumento dos gastos para o desenvolvimento de infraestruturas de saúde são os principais fatores atribuíveis ao crescimento do mercado de tratamento da gravidez extrauterina.

Também conhecida como gravidez ectópica, a gravidez extrauterina é uma condição rara da gravidez que se desenvolve fora do útero. Nesta condição médica, o óvulo fertilizado implanta-se fora do útero. Esta condição pode causar danos nos órgãos próximos e causar perdas de sangue com risco de vida.

A crescente designação especial das autoridades reguladoras é um factor importante que promove o crescimento do mercado. Aumento dos gastos com o desenvolvimento de infraestruturas de saúde , aumento da prevalência da gravidez ectópica em todo o mundo, aumento das iniciativas do governo para promover a consciencialização nas áreas atrasadas, aumento da prevalência de inflamação ou infeção no útero e aumento da taxa de colaboração estratégica entre o mercado players são outros fatores que também fomentam o crescimento do mercado. O aumento do potencial nas economias emergentes e o aumento da utilização de pílulas contracetivas criarão oportunidades lucrativas de crescimento do mercado.

No entanto, a escassez de profissionais médicos qualificados e o cenário de reembolso desfavorável nas economias em desenvolvimento e subdesenvolvidas representarão um grande desafio para o crescimento do mercado. Além disso, os elevados custos associados às competências em investigação e desenvolvimento, a falta de sensibilização entre as mulheres nas economias subdesenvolvidas e atrasadas, as hemorragias elevadas durante o tratamento cirúrgico e as más instalações de saúde nas economias subdesenvolvidas irão inviabilizar ainda mais a taxa de crescimento do mercado.

This extrauterine pregnancy treatment market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on extrauterine pregnancy treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Extrauterine Pregnancy Treatment Market Scope and Market Size

The extrauterine pregnancy treatment market is segmented on the basis of types, treatment, drugs, route of administration, distribution channel and end-users. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• Based on types, the extrauterine pregnancy treatment market is segmented into tubal pregnancy, non-tubal ectopic pregnancy and heterotopic pregnancy
• Based on treatment, the extrauterine pregnancy treatment market is segmented as medication, chemotherapy and surgery
• Based on drugs, the extrauterine pregnancy treatment market is segmented as methotrexate, misoprostol and others
• Based on the route of administration, the extrauterine pregnancy treatment market is segmented into oral and parenteral
• Based on the distribution channel, the extrauterine pregnancy treatment market is segmented as direct, online pharmacy, retailers and others
• Based on end-users, the extrauterine pregnancy treatment market is segmented into hospitals, homecare, specialty clinics and others

Extrauterine Pregnancy Treatment Market Country Level Analysis

The extrauterine pregnancy treatment market is analysed and market size insights and trends are provided by country, types, treatment, drugs, route of administration, distribution channel and end-users as referenced above.

The countries covered in the extrauterine pregnancy treatment market report are U.S., Canada and Mexico in North America, Peru, Brazil, Argentina and Rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).

North America dominates the extrauterine pregnancy treatment market owing to the earliest adoption of innovative technologies, growing research and development capacities and rise in the consumption rate of birth control pills. Asia-Pacific is projected to undergo substantial gains during the forecast period and score the highest CAGR. This is because of the rising expenditure to develop healthcare infrastructure and increase in the research and development activities.

The country section of the extrauterine pregnancy treatment market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

The extrauterine pregnancy treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to extrauterine pregnancy treatment market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the extrauterine pregnancy treatment market in the growth period.

Competitive Landscape and Extrauterine Pregnancy Treatment Market Share Analysis

The extrauterine pregnancy treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to extrauterine pregnancy treatment market.

Alguns dos principais players que operam no mercado do tratamento da gravidez extrauterina são a Antares Pharma, Sun Pharmaceutical Industries Ltd, Pfizer Inc, Bayer AG, Zydus Cadila, Amneal Pharmaceuticals LLC, Hikma Pharmaceuticals PLC, Mylan NV, Accord Healthcare, Teva Pharmaceutical Industries Ltd, Quad Pharma cc, Fresenius SE & Co. , Promega Corporation e QIAGEN, entre outros.

SKU-50497